SSY Group (HKG:2005) said it won a bid to supply 12 medicines to government-linked healthcare facilities in China, according to a Hong Kong bourse filing Tuesday.

The company had submitted tenders for 14 medicines, of which it won 12, namely diprophylline injection, formoterol fumarate inhalation solution, fluvoxamine maleate tablets, lornoxicam for injection, epinephrine hydrochloride injection, bromhexine hydrochloride injection, multiple electrolyte injection, multiple electrolyte injection (II), nicorandil tablets, salbutamol sulfate injection, benidipine hydrochloride tablets, and sodium bicarbonate injection.